أزمة كورونا العالمية (2020)‎ و فرصة نمو أعمال الصناعة الصيدلانية

Abstract EN

This article aims to analyze the economic aspect of the Corona crisis of 2020, and highlight its impact on the business sector of the pharmaceutical industry.

Among the most important results: The global Corona crisis led to a decline in demand in most business sectors, except for the pharmaceutical products industry business sector and medication, which has witnessed a recovery, with high sales and exports of these products.

The Corona crisis has many economic and non-economic implications and causes.

Among the most important recommendations: It is necessary to manage the crisis according to business ethics, and it is very important to train human resources on crisis management mechanisms to serve the growth of institutions.

It is important to strengthen international cooperation by concluding more agreements prohibiting biomedical practices that harm people and the environment, and it is necessary to review the legal period for intellectual property protection and reduce it from 20 years to 5 years at most, so that developing countries can contribute to production and innovation in the pharmaceutical business sector.